Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2007-07-10
2007-07-10
Meller, Michael (Department: 1655)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C435S183000, C514S052000
Reexamination Certificate
active
10155922
ABSTRACT:
The present invention provides oligopeptides having morphogenesis promoting activity and in particular, hair promoting activity. The oligopeptides may be in monomer form, monomer having a reactive substance bound form or as a polymer, such as a dimer including a homodimer; heterodimer; homotrimer; or heterodimer. The present invention also provides monoclonal antibodies that specifically recognize a 220 kDa antigen of epithelial new hair follicles; hybridomas producing such antibody; and methods and kits for assaying hair growth in mammalian subjects.
REFERENCES:
patent: 3755560 (1973-08-01), Dickert et al.
patent: 4254105 (1981-03-01), Fukuda
patent: 4421769 (1983-12-01), Dixon et al.
patent: 4861764 (1989-08-01), Samour et al.
patent: 4960764 (1990-10-01), Figueroa, Jr. et al.
patent: 5082866 (1992-01-01), Wong et al.
patent: 5196410 (1993-03-01), Francoeur et al.
patent: 5616471 (1997-04-01), Yuspa
patent: 5726298 (1998-03-01), Hirai et al.
patent: 5837239 (1998-11-01), Hirai et al.
patent: 6299900 (2001-10-01), Reed et al.
patent: 6333057 (2001-12-01), Crandall
patent: 6358541 (2002-03-01), Goodman
patent: 6372890 (2002-04-01), Koshida
patent: 6376557 (2002-04-01), Zaveri
patent: 2002/0048558 (2002-04-01), Niemiec et al.
patent: 2002/0051760 (2002-05-01), Hirai et al.
patent: 0 698 666 (1996-02-01), None
patent: 0 698 666 (1996-02-01), None
patent: 1 008 603 (2000-06-01), None
patent: 1156334 (2001-11-01), None
patent: 1156334 (2001-11-01), None
patent: 1 288 221 (2003-03-01), None
patent: 1310511 (2003-05-01), None
patent: 1310511 (2003-05-01), None
patent: 6-25295 (1994-02-01), None
patent: 6-25295 (1994-02-01), None
patent: 9-12432 (1997-01-01), None
patent: WO 93/08213 (1993-04-01), None
patent: WO 98/22505 (1998-05-01), None
patent: WO 01/94382 (2001-12-01), None
Goyal, A. et al. (1998). “Characterization of Rat Epimorphin/Syntaxin 2 Expression Suggests a Role in Crypt-Villus Morphogenesis,”Am. J. Physiol.275: G114-G124.
Hirai, Y. et al. (1992). “Epimorphin: A Mesenchymal Protein Essential for Epithelial Morphogenesis,”Cell.69:471-481.
Hirai, Y. et al. (1998). “Epimorphin Functions as a Key Morhporegulator for Mammary Epithelial Cells,”Journal of Cell Biololgy140(1):159-169.
Hirai, Y.et al. (1994). “Sodium-Dodecyl-Sulfate-Resistant Complex Formation of Epimorphin Monomers and Interaction of the 150-kDa Complex with the Cell Surface,”European Journal of Biochemistry225: 1133-1139.
Koshida, S. and Hirai, Y. (1997). “Identification of Cellular Recognition Sequence of Epimorphin and Critical Role of Cell-Epimorphin Interaction in Lung Branching Morphogenesis,”Biochemical and Biophysical Research Communications234(2):522-525.
Lehnert, L. et al. (2001). “Autocrine Stimulation of Human Pancreatic Duct-like Development by Soluble Isoforms of Epimorphin In Vitro,”The Journal of Cell Biology152(5):911-922.
Matsuki, Y. et al. (1995). “Gene Expression of Epimorphin in Rat Incisor Ameloblasts,”Archs. Oral. Biol.40(2): 161-164.
Mezei, M. (1985). “Liposomes As A Skin Drug Delivery System,”Topics in Pharmaceutical Sciences, Proceedings of the 45th International Congress of Pharmaceutical Sciences of F.I.P., held in Montreal, Canada, Breimer, et al. (eds.), Elsevier Science Publishers, pp. 345-358.
Mori, M. and Miyazaki, K. 2000). “Factors Affecting Morphogenesis of Rabbit Gallbladder Epithelial Cells Cultured in Collagen Gels,”Cell Tissue Res.300: 331-344.
Nakajima, H. et al. (2000). “Expression of Random Peptide Fused to Invasin on Bacterial Cell Surface for Selection of Cell-Targeting Peptides,”Gene260:121-131.
Oka, Y. and Hirai, Y. (1996). “Inductive Influences of Epimorphin on Endothelial CellsIn Vitro,” Experimental Cell Research222: 189-198, Article No. 0024.
Terasaki, Y. et al. (2000). “Increased Expression of Epimorphin in Bleomycin-Induced Pulmonary Fibrosis in Mice,”Am. J. Respir. Cell Mol. Biol.23: 168-174.
Watanabe, S. et al. (1998). “A Novel Hepatic Stellate (Ito) Cell-Derived Protein, Epimorphin, Plays a Key Role in the Late Stages of Liver Regeneration,”Biochemical and Biophysical Research Communications250: 486-490, Article No. RC989339.
Zhang, L. et al. (1998). “Immunohistochemical Distribution of Epimorphin in Human and Mouse Tissues,”Histochemical Journal30: 903-908.
Hirai, Y. (1993) “Molecular Cloning of Human Epimorphin: Identification of Isoforms and Their Unique Properties,”Biochemical and Biophysical Research Communications191(3):1332-1337.
Akiyama, M. et al., (1999) “Epimorphin expression during human foetal hair follicle development”British Journal of Dermatology, 141:447-452.
Hirai, Y. et al., (May 14, 2001) “Epimorphin mediates mammary luminal morphogenesis through control of C/EBPβ”The Journal of Cell Biology, 153(4):785-794.
Supplementary European Search Report mailed on Jan. 26, 2006 for EP Application No. 04700512.9, 3 pages.
Takebe, K. et al. (Nov. 2003). “Epimorphin Acts to Induce Hair Follicle Anagen in C57BL/6 Mice,”The FASEB Journal17:2037-2047.
Hirai Yohei
Koshida Shogo
Murakami Kayoko
Oka Yumiko
Shinagawa Toko
Meller Michael
Morrison & Foerster / LLP
Sumitomo Electric Industries Ltd.
LandOfFree
Oligopeptides for promoting hair growth does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Oligopeptides for promoting hair growth, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Oligopeptides for promoting hair growth will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3821604